• 1
    Baggiolini M, Dewald B, Moser B. Human chemokines: An update. Annu Rev Immunol 1997; 15: 675705.
  • 2
    Moser B, Wolf M, Walz A, Loetscher P. Chemokines: Multiple levels of leukocyte migration control. Trends Immunol 2004; 25: 7584.
  • 3
    Bevilacqua M, Butcher E, Furie B et al. Selectins: A family of adhesion receptors. Cell 1991; 67: 233.
  • 4
    Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998; 279: 381384.
  • 5
    Sallusto F, Mackay CR. Chemoattractants and their receptors in homeostasis and inflammation. Curr Opin Immunol 2004; 16: 724731.
  • 6
    Iellem A, Mariani M, Lang R et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR 4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 2001; 194: 847853.
  • 7
    Colantonio L, Iellem A, Sinigaglia F, D'Ambrosio D. Skin-homing CLA + T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309. Eur J Immunol 2002; 32: 35063514.
  • 8
    Curiel TJ, Coukos G, Zou L et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942949.
  • 9
    Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2001; 2: 11261132.
  • 10
    Wysocki CA, Jiang Q, Panoskaltsis-Mortari A et al. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood 2005; 106: 33003307.
  • 11
    Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005; 201: 10371044.
  • 12
    Schaniel C, Pardali E, Sallusto F et al. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J Exp Med 1998; 188: 451463.
  • 13
    Tang HL, Cyster JG. Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells. Science 1999; 284: 819822.
  • 14
    Selvan RS, Zhou LJ, Krangel MS. Regulation of I-309 gene expression in human monocytes by endogenous interleukin-1. Eur J Immunol 1997; 27: 687694.
  • 15
    Kleinewietfeld M, Puentes F, Borsellino G, Battistini L, Rotzschke O, Falk K. CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. Blood 2005; 105: 28772886.
  • 16
    Chen D, Zhang N, Fu S et al. CD4+CD25+ T Regulatory Cells Inhibit the Islet Innate Immune Response and Promote Islet Engraftment. Diabetes 2006; 55: 10111021.
  • 17
    Cerf-Bensussan N, Jarry A, Brousse N, Lisowska-Grospierre B, Guy-Grand D, Griscelli C. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol 1987; 17: 12791285.
  • 18
    Lehmann J, Huehn J, De La Rosa M et al. Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25− regulatory T cells. Proc Natl Acad Sci U.S.A. 2002; 9: 1303113036.
  • 19
    McHugh RS, Whitters MJ, Piccirillo CA et al. CD4(+)CD25(+) immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 16: 311323.
  • 20
    Banz A, Peixoto A, Pontoux C, Cordier C, Rocha B, Papiernik M. A unique subpopulation of CD4+ regulatory T cells controls wasting disease, IL-10 secretion and T cell homeostasis. Eur J Immunol 2003; 33: 24192428.
  • 21
    Huehn J, Siegmund K, Lehmann JC et al. Developmental stage, phenotype and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med 2004; 199: 303313.
  • 22
    Annacker O, Coombes JL, Malmstrom V et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med 2005; 202: 10511061.
  • 23
    Suffia I, Reckling SK, Salay G, Belkaid Y. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol 2005; 174: 54445455.
  • 24
    Stassen M, Fondel S, Bopp T et al. Human C D25+ regulatory T cells: Two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 2004; 34: 13031311.
  • 25
    Siegmund K, Feuerer M, Siewert C et al. Migration matters: Regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 2005; 106: 30973104.
  • 26
    Khan AI, Kubes P. L-selectin: An emerging player in chemokine function. Microcirculation 2003; 10: 351358.
  • 27
    Fu S, Yopp AC, Mao X et al. CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant 2004; 4: 6578.
  • 28
    Ochando JC, Yopp AC, Yang Y et al. Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. J Immunol 2005; 174: 69937005.
  • 29
    Szanya V, Ermann J, Taylor C, Holness C, Fathman CG. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol 2002; 169: 24612465.
  • 30
    Hiura T, Kagamu H, Miura S et al. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression. J Immunol 2005; 175: 50585066.
  • 31
    Ermann J, Hoffmann P, Edinger M et al. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood 2005; 105: 22202226.
  • 32
    Taylor PA, Panoskaltsis-Mortari A, Swedin JM et al. L-Selectin(hi) but not the L-selectin(lo) CD4 + 25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 2004; 104: 38043812.
  • 33
    Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000; 18: 593620 .
  • 34
    Flanagan K, Moroziewicz D, Kwak H, Horig H, Kaufman HL. The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells. Cell Immunol 2004; 231: 7584.
  • 35
    Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest 2005; 115: 19531962.
  • 36
    Tang Q, Adams JY, Tooley AJ et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006; 7: 8392.
  • 37
    Denning TL, Kim G, Kronenberg M. Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis. J Immunol 2005; 174: 74877491.
  • 38
    Lim HW, Hillsamer P, Kim CH. Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J Clin Invest 2004; 114: 16401649.
  • 39
    Zou L, Barnett B, Safah H et al. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res 2004; 64: 84518455.
  • 40
    Druey KM, Blumer KJ, Kang VH, Kehrl JH. Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature 1996; 379: 742746.
  • 41
    Kehrl JH. Heterotrimeric G protein signaling: Roles in immune function and fine-tuning by RGS proteins. Immunity 1998; 8: 110.
  • 42
    Agenes F, Bosco N, Mascarell L, Fritah S, Ceredig R. Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naive and regulatory T cells. Immunology 2005; 115: 179188.
  • 43
    Sarween N, Chodos A, Raykundalia C, Khan M, Abbas AK, Walker LS. CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J Immunol 2004; 173: 29422951.
  • 44
    Chen C, Lee WH, Yun P, Snow P, Liu CP. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J Immunol 2003; 171: 733744.
  • 45
    James MJ, Belaramani L, Prodromidou K et al. Anergic T cells exert antigen-independent inhibition of cell-cell interactions via chemokine metabolism. Blood 2003; 102: 21732179.
  • 46
    Mirenda V, Millington O, Lechler RI et al. Tolerant T cells display impaired trafficking ability. Eur J Immunol 2005; 35: 21462156.